{"_id": "34801556|None", "id": "34801556", "infons": {}, "passages": [{"infons": {"journal": "J Biol Chem. 2022 Jan;298(1):101437. doi: 10.1016/j.jbc.2021.101437. Epub 2021 ", "year": "2022", "article-id_pmc": "PMC8718947", "type": "title", "authors": "Chandran A, Rochet JC"}, "offset": 0, "text": "Shining a light on autophagy in neurodegenerative diseases.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "neurodegenerative diseases", "locations": [{"offset": 32, "length": 26}]}], "relations": []}, {"infons": {"type": "abstract"}, "offset": 60, "text": "Small-molecule modulators of autophagy have been widely investigated as potential therapies for neurodegenerative diseases. In a recent issue of JBC, Safren et al. described a novel assay that uses a photoconvertible fusion protein to identify compounds that alter autophagic flux. Autophagy inducers identified using this assay were found to either alleviate or exacerbate neurotoxicity in different cellular models of amyotrophic lateral sclerosis, challenging the notion that autophagy stimulation can be used as a one-size-fits-all therapy for neurodegenerative disease.", "sentences": [], "annotations": [{"id": "7", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "neurodegenerative diseases", "locations": [{"offset": 156, "length": 26}]}, {"id": "8", "infons": {"type": "Disease", "valid": false, "normalized_id": null, "biotype": "disease"}, "text": "JBC", "locations": [{"offset": 205, "length": 3}]}, {"id": "9", "infons": {"identifier": "MESH:D020258", "type": "Disease", "valid": true, "normalized": ["D020258"], "database": "ncbi_mesh", "normalized_id": "D020258", "biotype": "disease", "name": "Neurotoxicity Syndromes", "accession": "@DISEASE_Neurotoxicity_Syndromes"}, "text": "neurotoxicity", "locations": [{"offset": 434, "length": 13}]}, {"id": "10", "infons": {"identifier": "MESH:D000690", "type": "Disease", "valid": true, "normalized": ["D000690"], "database": "ncbi_mesh", "normalized_id": "D000690", "biotype": "disease", "name": "Amyotrophic Lateral Sclerosis", "accession": "@DISEASE_Amyotrophic_Lateral_Sclerosis"}, "text": "amyotrophic lateral sclerosis", "locations": [{"offset": 480, "length": 29}]}, {"id": "11", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "neurodegenerative disease", "locations": [{"offset": 608, "length": 25}]}], "relations": []}], "relations": [], "pmid": 34801556, "pmcid": null, "meta": {}, "date": "2022-01-01T00:00:00Z", "journal": "J Biol Chem", "authors": ["Chandran A", "Rochet JC"], "relations_display": []}
